Positions

Selected Publications

Academic Article

Year Title Altmetric
2023 Latest Advances in Laboratory Detection of Mycoplasma genitalium..  Journal of Clinical Microbiology.  61:e0079021. 2023
2023 Prevalence of Mycoplasma genitalium infection and macrolide resistance in pregnant women receiving prenatal care.  International Journal of Gynecology and Obstetrics.  160:341-344. 2023
2022 Omadacycline Is Highly Active in Vitro against Mycoplasma genitalium.  Microbiology Spectrum.  10. 2022
2022 Antimicrobial susceptibilities and mechanisms of resistance of commensal and invasive Mycoplasma salivarium isolates.  Frontiers in Microbiology.  13. 2022
2022 Antimicrobial Susceptibility Profiles and Genetic Characteristics of Mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019.  Infection and Drug Resistance.  15:4443-4452. 2022
2021 Trichomonas vaginalis detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG test.  Journal of Clinical Microbiology.  59. 2021
2021 Mycoplasma genitalium Infection in Young Women Without Urogenital Symptoms Presenting to a Community-Based Emergency Department in Birmingham, Alabama.  Sexually Transmitted Diseases.  48:e27-e29. 2021
2021 Septic polyarthritis with Mycoplasma salivarium in a patient with common variable immunodeficiency: case report and review of the literature..  Access Microbiology.  3:000221. 2021
2020 Hyperammonemia syndrome due to Ureaplasma urealyticum in a kidney transplant recipient: A case of disseminated disease from a fluoroquinolone-resistant isolate.  Transplant Infectious Disease.  22. 2020
2020 Macrolide-resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?.  Transplant Infectious Disease.  22. 2020
2020 Molecular characterization of Mycoplasma pneumoniae isolates in the United States from 2012 to 2018.  Journal of Clinical Microbiology.  58. 2020
2020 In vitro activities of eravacycline and other antimicrobial agents against human mycoplasmas and ureaplasmas.  Antimicrobial Agents and Chemotherapy.  64. 2020
2020 Evaluation of commercial molecular diagnostic methods for detection and determination of macrolide resistance in mycoplasma pneumoniae.  Journal of Clinical Microbiology.  58. 2020
2020 Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG test.  Journal of Clinical Microbiology.  58. 2020
2019 Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection.  Sexually Transmitted Diseases.  46:E101-E104. 2019
2019 Evaluation of the ELITe InGenius PCR platform for detection of Mycoplasma pneumoniae.  Journal of Clinical Microbiology.  57. 2019
2019 Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline.  International Journal of STD and AIDS.  30:512-514. 2019
2019 Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infections.  Journal of Allergy and Clinical Immunology.  143:1183-1197.e7. 2019
2019 Differential susceptibility of Mycoplasma and Ureaplasma species to compound-enhanced copper toxicity.  Frontiers in Microbiology.  10. 2019
2019 Macrolide-resistant mycoplasma pneumoniae in the United States as determined from a national surveillance program.  Journal of Clinical Microbiology.  57. 2019
2019 Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-Associated mutations in heterosexual african American couples in Alabama.  Sexually Transmitted Diseases.  46:18-24. 2019
2019 Mycoplasma pneumoniae Carriage with De Novo Macrolide-Resistance and Breakthrough Pneumonia.  Pediatrics.  144. 2019
2018 In vitro activities of the benzoquinolizine fluoroquinolone levonadifloxacin (WCK 771) and other antimicrobial agents against mycoplasmas and ureaplasmas in humans, including isolates with defined resistance mechanisms.  Antimicrobial Agents and Chemotherapy.  62. 2018
2018 A rapid and simple chemical method for the preparation of Ag colloids for surface-enhanced Raman spectroscopy using the Ag mirror reaction.  Vibrational Spectroscopy.  98:1-7. 2018
2018 Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens.  Diagnostic Microbiology and Infectious Disease.  91:123-125. 2018
2018 High prevalence of multidrug-resistant mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama.  Clinical Infectious Diseases.  66:796-798. 2018
2018 Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity.  PLoS One.  13. 2018
2017 Mycoplasma pneumoniae from the respiratory tract and beyond.  Clinical Microbiology Reviews.  30:747-809. 2017
2017 Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data.  Future Microbiology.  12:119-129. 2017
2017 In vitro activities of gepotidacin (GSK2140944) and other antimicrobial agents against human mycoplasmas and ureaplasmas.  Antimicrobial Agents and Chemotherapy.  61. 2017
2017 Shaken or stirred?: Comparison of methods for dispersion of Mycoplasma pneumoniae aggregates for persistence in vivo.  Journal of Microbiological Methods.  132:56-62. 2017
2015 Comparative genome analysis of Mycoplasma pneumoniae.  BMC Genomics.  16. 2015
2015 Macrolide-resistant Mycoplasma pneumoniae, United States 2015
2015 Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.  Science Translational Medicine.  7:284ra59. 2015
2015 The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: A cross-sectional study.  ACP journal club.  162:241-247. 2015
2014 Suppression of antimicrobial peptide expression by Ureaplasma species.  Infection and Immunity.  82:1657-1665. 2014
2012 Molecular methods for the detection of mycoplasma and ureaplasma infections in humans: A paper from the 2011 William Beaumont Hospital symposium on molecular pathology 2012
2012 Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.  BMC Microbiology.  12. 2012
2012 Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.  Antimicrobial Agents and Chemotherapy.  56:2780-2783. 2012
2012 Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.  Biochemical Pharmacology.  83:995-1004. 2012
2011 Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis.  Journal of Clinical Microbiology.  49:3325-3328. 2011
2011 Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.  Journal of Clinical Pharmacology.  51:1264-1275. 2011
2011 Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.  Journal of Clinical Microbiology.  49:2818-2826. 2011
2011 Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants.  Pediatric Research.  69:442-447. 2011
2011 Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp..  International Journal of Antimicrobial Agents.  37:377-379. 2011
2011 Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia 2011
2011 Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia.  Pediatrics.  127. 2011
2010 Detection and characterization of human Ureaplasma species and serovars by real-time PCR.  Journal of Clinical Microbiology.  48:2715-2723. 2010
2009 Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis.  Seminars in Fetal and Neonatal Medicine.  14:190-199. 2009
2009 Ureaplasma parvum as a cause of sternal wound infection.  Journal of Clinical Microbiology.  47:1976-1978. 2009
2007 Possible effects of early treatments of Hsp90 inhibitors on preventing the evolution of drug resistance to other anti-cancer drugs.  Current Medicinal Chemistry.  14:223-232. 2007
2006 Effectiveness of Hsp90 inhibitors as anti-cancer drugs.  Mini-Reviews in Medicinal Chemistry.  6:1137-1143. 2006
2005 Epigenetic regulation of trinucleotide repeat expansions and contractions and the "biased embryos" hypothesis for rapid morphological evolution.  Current Genomics.  6:145-155. 2005
2005 Hsp90 and environmental impacts on epigenetic states: A model for the trans-generational effects of diethylstibesterol on uterine development and cancer.  Human Molecular Genetics.  14. 2005
2003 Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution.  Nature Genetics.  33:70-74. 2003

Chapter

Year Title Altmetric
2014 Mycoplasmas and Ureaplasmas of Humans.  1587-1609. 2014
2013 Mycoplasma and ureaplasma.  229-281. 2013
2011 Ureaplasma.  469-487. 2011

Education And Training

  • Doctor of Science in Environmental Science, University of Alabama at Birmingham 2006
  • Master of Sciences or Mathematics in Molecular Biology, University of the Chinese Academy of Sciences 1997

    • Full Name

  • Li Xiao